| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate |
2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0dac5ef39b8671230a4ff94af4965c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d419fca8aae27f8992a9f7d49c3816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2c7c3b849d199dad1c8ab3e0ab861a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e715c61332b13a7acb28b17a0c2252e2 |
| publicationDate |
2009-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-20090924-L |
| titleOfInvention |
Pharmaceutical compound containing saredutant and a selective inhibitor of serotonin reuptake or an inhibitor of serotonin / norepinephrine reuptake in combination |
| abstract |
Pharmaceutical compositions containing (S) - (-) - N- [4- (4-acetamido-4-phenylpiperidin-1-yl) -2- (3,4-dichlorophenyl) butyl] -N-methylbenzamide or a pharmaceutical are disclosed. acceptable salt thereof in combination with a selective inhibitor for serotonin reuptake or with an inhibitor for serotonin / norepinephrine reuptake. |
| priorityDate |
2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |